Literature DB >> 12426395

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.

Akihiro Ito1, Yoshiharu Kawaguchi, Chun-Hsiang Lai, Jeffrey J Kovacs, Yuichiro Higashimoto, Ettore Appella, Tso-Pang Yao.   

Abstract

The tumor suppressor p53 is stabilized and activated in response to cellular stress through post-translational modifications including acetylation. p300/CBP-mediated acetylation of p53 is negatively regulated by MDM2. Here we show that MDM2 can promote p53 deacetylation by recruiting a complex containing HDAC1. The HDAC1 complex binds MDM2 in a p53-independent manner and deacetylates p53 at all known acetylated lysines in vivo. Ectopic expression of a dominant-negative HDAC1 mutant restores p53 acetylation in the presence of MDM2, whereas wild-type HDAC1 and MDM2 deacetylate p53 synergistically. Fibroblasts overexpressing a dominant negative HDAC1 mutant display enhanced DNA damage-induced p53 acetylation, increased levels of p53 and a more pronounced induction of p21 and MDM2. These results indicate that acetylation promotes p53 stability and function. As the acetylated p53 lysine residues overlap with those that are ubiquitylated, our results suggest that one major function of p53 acetylation is to promote p53 stability by preventing MDM2-dependent ubiquitylation, while recruitment of HDAC1 by MDM2 promotes p53 degradation by removing these acetyl groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426395      PMCID: PMC137207          DOI: 10.1093/emboj/cdf616

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Authors:  E Kobet; X Zeng; Y Zhu; D Keller; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

4.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 5.  Post-translational modifications and activation of p53 by genotoxic stresses.

Authors:  E Appella; C W Anderson
Journal:  Eur J Biochem       Date:  2001-05

6.  The MDM2 RING-finger domain is required to promote p53 nuclear export.

Authors:  R K Geyer; Z K Yu; C G Maki
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

7.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.

Authors:  S D Boyd; K Y Tsai; T Jacks
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

8.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

9.  Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.

Authors:  S Nakamura; J A Roth; T Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 10.  Control of p53 ubiquitination and nuclear export by MDM2 and ARF.

Authors:  Y Zhang; Y Xiong
Journal:  Cell Growth Differ       Date:  2001-04
View more
  210 in total

1.  Critical role for a central part of Mdm2 in the ubiquitylation of p53.

Authors:  Erik Meulmeester; Ruth Frenk; Robert Stad; Petra de Graaf; Jean-Christophe Marine; Karen H Vousden; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 2.  Getting into position: the catalytic mechanisms of protein ubiquitylation.

Authors:  Lori A Passmore; David Barford
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

Review 3.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

Review 4.  Histone deacetylases in kidney development: implications for disease and therapy.

Authors:  Shaowei Chen; Samir S El-Dahr
Journal:  Pediatr Nephrol       Date:  2012-06-22       Impact factor: 3.714

Review 5.  Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment.

Authors:  Daisy Bustos; Corey E Bakalarski; Yanling Yang; Junmin Peng; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2012-06-23       Impact factor: 5.911

6.  Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1.

Authors:  Yingjuan Qian; Yong-Sam Jung; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-21       Impact factor: 11.205

Review 7.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

8.  Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; A Aboukameel; Zhiwei Wang; Sanjeev Banerjee; Syed F Zafar; Anton-Scott Goustin; K Almhanna; Dajun Yang; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Curr Cancer Drug Targets       Date:  2010-05       Impact factor: 3.428

9.  MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output.

Authors:  Lihong Chen; Zhenyu Li; Aleksandra K Zwolinska; Matthew A Smith; Brittany Cross; John Koomen; Zhi-Min Yuan; Thomas Jenuwein; Jean-Christophe Marine; Kenneth L Wright; Jiandong Chen
Journal:  EMBO J       Date:  2010-06-29       Impact factor: 11.598

10.  HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.

Authors:  Jing Qi; Sandeep Singh; Wei-Kai Hua; Qi Cai; Shi-Wei Chao; Ling Li; Hongjun Liu; Yinwei Ho; Tinisha McDonald; Allen Lin; Guido Marcucci; Ravi Bhatia; Wei-Jan Huang; Chung-I Chang; Ya-Huei Kuo
Journal:  Cell Stem Cell       Date:  2015-09-18       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.